Clinical trial
Long Term Follow-up for Participants Who Previously Received a Single Intravitreal Injection of MCO-010 Optogenetic Therapy in the STARLIGHT Study
NCT06048185 is registered in ClinicalTrials.gov with Nanoscope Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term Follow-up for Participants Who Previously Received a Single Intravitreal Injection of MCO-010 Optogenetic Therapy in the STARLIGHT Study
- Lead sponsor
- Nanoscope Therapeutics Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 19, 2023
- Completion date
- July 31, 2027
- Enrollment
- 6 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.